Skip to main content
. 2018 Feb 7;9(2):182. doi: 10.1038/s41419-017-0258-2

Fig. 1. Downregulation of miR-143-3p is correlated with poor clinical outcomes in GBC patients.

Fig. 1

a A portion of the cluster analysis of the miRNA expression profiles of the GBC tissues and NAT counterparts from our previous microarray results. b Scatterplots of the relative expression levels of miR-143-3p in the GBC tissues and their corresponding NATs. miR-143-3p expression was calculated and expressed as the miR-143-3p/U6 expression ratio (2−ΔCT). P = 0.0021. c Comparison of the miR-143-3p expression levels between the GBC tissues and their corresponding NATs. d Kaplan−Meier overall survival curve of GBC patients based on miR-143-3p expression. P < 0.001